PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
Data generation and assessment | ARN | Regulatory risk management | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bis(2-ethylhexyl) fumarate | 205-448-2 | 141-02-6 | - | - | 3 | - | - | - | - | - | - | Details |
Diisobutyl adipate | 205-450-3 | 141-04-8 | - | - | 1 | - | 1 | - | - | - | - | Details |
6,10-dimethylundeca-3,5,9-trien-2-one | 205-457-1 | 141-10-6 | - | - | - | - | 1 | - | - | - | - | Details |
2,6,10-trimethylundec-9-enal | 205-460-8 | 141-13-9 | - | - | 1 | - | - | - | - | - | - | Details |
Bis(2-(2-butoxyethoxy)ethyl) adipate | 205-465-5 | 141-17-3 | - | - | 2 | - | 1 | - | - | - | - | Details |
Bis(2-butoxyethyl) adipate | 205-466-0 | 141-18-4 | - | - | 1 | - | 1 | - | - | - | - | Details |
Methyl ricinoleate | 205-472-3 | 141-24-2 | - | - | - | - | 1 | - | - | - | - | Details |
Butyl acrylate | 205-480-7 | 141-32-2 | 1 | - | 1 | - | 1 | - | - | - | - | Details |
2-aminoethanol | 205-483-3 | 141-43-5 | 1 | - | 2 | - | - | - | - | - | - | Details |
Sodium formate | 205-488-0 | 141-53-7 | - | - | 1 | - | - | - | - | - | - | Details |
Trichloro(propyl)silane | 205-489-6 | 141-57-1 | - | - | 1 | - | 1 | - | - | - | - | Details |
Decamethyltetrasiloxane | 205-491-7 | 141-62-8 | 1 | 1 | 2 | - | 1 | - | 1 | - | - | Details |
Dodecamethylpentasiloxane | 205-492-2 | 141-63-9 | 1 | 1 | 3 | - | 1 | - | 1 | - | - | Details |
Ethyl acetate | 205-500-4 | 141-78-6 | - | - | 2 | - | - | - | - | - | - | Details |
4-methylpent-3-en-2-one | 205-502-5 | 141-79-7 | - | - | - | - | 1 | - | - | - | - | Details |
O-isopropyl ethylthiocarbamate | 205-517-7 | 141-98-0 | - | - | 5 | - | 1 | 1 | - | - | - | Details |
Anilinium chloride | 205-519-8 | 142-04-1 | - | - | - | - | 1 | - | - | - | - | Details |
Hexyl methacrylate | 205-521-9 | 142-09-6 | - | - | - | - | 1 | - | - | - | - | Details |
Bis(2-ethylhexyl) maleate | 205-524-5 | 142-16-5 | - | - | 2 | - | - | - | - | - | - | Details |
2,3-dihydroxypropyl laurate | 205-526-6 | 142-18-7 | - | - | - | - | 1 | - | - | - | - | Details |
Allyl heptanoate | 205-527-1 | 142-19-8 | - | - | 3 | - | 1 | - | - | - | - | Details |
Diallyl 2,2'-oxydiethyl dicarbonate | 205-528-7 | 142-22-3 | - | - | 1 | - | - | - | - | - | - | Details |
Cyclopentene | 205-532-9 | 142-29-0 | - | - | - | - | 1 | - | - | - | - | Details |
Sodium octyl sulphate | 205-535-5 | 142-31-4 | - | - | - | - | 1 | - | - | - | - | Details |
Sodium hydrogen glutamate | 205-538-1 | 142-47-2 | - | - | 3 | - | - | - | - | - | - | Details |